Smoking Cessation And Nicotine De-addiction Market size to grow by USD 24,529.75 million from 2022 to 2027, North America to account for 32% of the market growth

NEW YORK, May 15, 2023 /PRNewswire/ — The smoking cessation and nicotine de-addiction market size is estimated to grow by USD 24529.75 million during 2023-2027. However, the growth momentum will be progressing at a CAGR of 12.59% during the forecast period. The market is segmented by Distribution Channel (Drug stores and retailers, Hospital pharmacies, and Online retail), Product (E-cigarette, NRT, and Drug therapy), and Geography (North America, Europe, Asia, and Rest of World (ROW)). The smoking cessation and nicotine de-addiction market share growth by the drug stores and retailers segment will be significant during the forecast period. The growth of this segment is primarily attributed to the increasing adoption of smoking cessation and nicotine de-addiction products, which is driven by an increase in the global demand for the smoking cessation and nicotine de-addiction industry.

Discover market potential and make informed business decisions based on qualitative and quantitative evidence highlighted in Technavio reports- Download the PDF Sample Report

Information Services Market Insights –

• Vendors: 15+, Including Alchem International Pvt. Ltd., Alkalon AS, Alvogen, Axcentria Pharmaceuticals, British American Tobacco Plc, Cambrex Corp., CHEMNOVATIC Sp. z o.o. Sp. k, Cipla Ltd., Dr Reddys Laboratories Ltd., Enorama Pharma AB, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson, Lil Drug Store Products Inc., Perrigo Co. Plc, Pfizer Inc., Philip Morris International, Qnovia, Tvape, Walgreen Co., among others
• Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
• Segments: Distribution Channel (Drug stores and retailers, Hospital pharmacies, and Online retail), Product (E-cigarette, NRT, and Drug therapy), and Geography (North America, Europe, Asia, and Rest of World (ROW))

To understand more about the information services market, request a Free sample report

In 2017, the smoking cessation and nicotine de-addiction market was valued at USD 19410.65 million. From a regional perspective, North America held the largest market share, valued at 32%. The smoking cessation and nicotine de-addiction market size is estimated to grow by USD 24529.75 million from 2023 to 2027 at a CAGR of 12.59% according to Technavio.

Smoking cessation and nicotine de-addiction market – Customer Landscape
To help companies evaluate and develop growth strategies, the report outlines –

• Key purchase criteria
• Adoption rates
• Adoption lifecycle
• Drivers of price sensitivity
• For highlights on customer landscape analysis, download a sample!

Global Smoking Cessation and Nicotine De-addiction Market – Vendor Insights

The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market’s competitive landscape and offers information on several market vendors including –

• Alchem International Pvt. Ltd.
• Alkalon AS
• Alvogen
• Axcentria Pharmaceuticals
• British American Tobacco Plc
• Cambrex Corp.
• CHEMNOVATIC Sp. z o.o. Sp. k
• Cipla Ltd.
• Dr. Reddys Laboratories Ltd.
• Enorama Pharma AB
• Imperial Brands Plc
• Japan Tobacco Inc.
• Johnson & Johnson
• Lil Drug Store Products Inc.

Global Smoking Cessation And Nicotine De-addiction Market – Market Dynamics

Market Drivers

• Rising adoption of online retailing
• Increasing number of people trying to quit smoking
• Growing health awareness among consumers

Market Trends

• New marketing initiatives
• Rising number of organized retailing outlets distributing nicotine patches
• Increasing availability through various distribution channels

Market Challenges

• Health issues associated with smoking cessation products
• Increasing use of e-cigarettes among teenagers
• Stringent regulations

Drivers, & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a free sample report!

The smoking cessation and nicotine de-addiction market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.

Why Buy?

• Add credibility to strategy
• Analyzes competitor’s offerings 
• Get a holistic view of the market

Grow your profit margin with Technavio- Buy the Report

What are the key data covered in this Smoking Cessation And Nicotine De-addiction Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the Smoking Cessation And Nicotine De-addiction Market between 2023 and 2027
• Precise estimation of the size of the Smoking Cessation And Nicotine De-addiction Market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the Smoking Cessation And Nicotine De-addiction Market industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of Smoking Cessation And Nicotine De-addiction Market vendors

Gain instant access to 17,000+ market research reports. 

Technavio’s SUBSCRIPTION platform

Related Reports: 

Tobacco Market- The tobacco market size is estimated to grow at a CAGR of 3.84% between 2022 and 2027. The market size is forecast to increase by USD 173.03 billion. 

Functional Chewing Gum Market- The functional chewing gum market is estimated to grow at a CAGR of 5.25% between 2022 and 2027. The size of the market is forecast to increase by USD 2828.5 million.

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global smoking cessation and nicotine de-addiction market 2017 – 2021 
• Exhibit 18: Historic Market Size – Data Table on Global smoking cessation and nicotine de-addiction market 2017 – 2021 ($ million)

• 4.2 Distribution channel Segment Analysis 2017 – 2021
• Exhibit 19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)

• 4.3 Product Segment Analysis 2017 – 2021
• Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments 
• Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)

• 6.2 Comparison by Distribution Channel 
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel

• 6.3 Drug stores and retailers – Market size and forecast 2022-2027 
• Exhibit 34: Chart on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Drug stores and retailers – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Drug stores and retailers – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Drug stores and retailers – Year-over-year growth 2022-2027 (%)

• 6.4 Hospital pharmacies – Market size and forecast 2022-2027 
• Exhibit 38: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)

• 6.5 Online retail – Market size and forecast 2022-2027
• Exhibit 42: Chart on Online retail – Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Online retail – Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Online retail – Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Online retail – Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Distribution Channel
• Exhibit 46: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

• 7.1 Market segments 
• Exhibit 47: Chart on Product – Market share 2022-2027 (%)
• Exhibit 48: Data Table on Product – Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 49: Chart on Comparison by Product
• Exhibit 50: Data Table on Comparison by Product

• 7.3 E-cigarette – Market size and forecast 2022-2027
• Exhibit 51: Chart on E-cigarette – Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on E-cigarette – Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on E-cigarette – Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on E-cigarette – Year-over-year growth 2022-2027 (%)

• 7.4 NRT – Market size and forecast 2022-2027
• Exhibit 55: Chart on NRT – Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on NRT – Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on NRT – Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on NRT – Year-over-year growth 2022-2027 (%)

• 7.5 Drug therapy – Market size and forecast 2022-2027
• Exhibit 59: Chart on Drug therapy – Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Drug therapy – Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Drug therapy – Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Drug therapy – Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Product 
• Exhibit 63: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 65: Chart on Market share by geography 2022-2027 (%)
• Exhibit 66: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 67: Chart on Geographic comparison
• Exhibit 68: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027
• Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027
• Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027
• Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027
• Exhibit 85: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 Germany – Market size and forecast 2022-2027
• Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.9 China – Market size and forecast 2022-2027
• Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.10 Canada – Market size and forecast 2022-2027
• Exhibit 97: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.11 India – Market size and forecast 2022-2027
• Exhibit 101: Chart on India – Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on India – Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on India – Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on India – Year-over-year growth 2022-2027 (%)

• 9.12 UK – Market size and forecast 2022-2027
• Exhibit 105: Chart on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on UK – Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on UK – Year-over-year growth 2022-2027 (%)

• 9.13 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

11 Vendor Landscape

• 11.2 Vendor landscape 
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 Alchem International Pvt. Ltd. 
• Exhibit 116: Alchem International Pvt. Ltd. – Overview
• Exhibit 117: Alchem International Pvt. Ltd. – Product / Service
• Exhibit 118: Alchem International Pvt. Ltd. – Key offerings

• 12.4 Alkalon AS 
• Exhibit 119: Alkalon AS – Overview
• Exhibit 120: Alkalon AS – Product / Service
• Exhibit 121: Alkalon AS – Key offerings

• 12.5 Alvogen 
• Exhibit 122: Alvogen – Overview
• Exhibit 123: Alvogen – Product / Service
• Exhibit 124: Alvogen – Key offerings

• 12.6 British American Tobacco Plc 
• Exhibit 125: British American Tobacco Plc – Overview
• Exhibit 126: British American Tobacco Plc – Business segments
• Exhibit 127: British American Tobacco Plc – Key news
• Exhibit 128: British American Tobacco Plc – Key offerings
• Exhibit 129: British American Tobacco Plc – Segment focus

• 12.7 Cambrex Corp. 
• Exhibit 130: Cambrex Corp. – Overview
• Exhibit 131: Cambrex Corp. – Product / Service
• Exhibit 132: Cambrex Corp. – Key news
• Exhibit 133: Cambrex Corp. – Key offerings

• 12.8 Cipla Ltd. 
• Exhibit 134: Cipla Ltd. – Overview
• Exhibit 135: Cipla Ltd. – Business segments
• Exhibit 136: Cipla Ltd. – Key news
• Exhibit 137: Cipla Ltd. – Key offerings
• Exhibit 138: Cipla Ltd. – Segment focus

• 12.9 Dr Reddys Laboratories Ltd. 
• Exhibit 139: Dr Reddys Laboratories Ltd. – Overview
• Exhibit 140: Dr Reddys Laboratories Ltd. – Business segments
• Exhibit 141: Dr Reddys Laboratories Ltd. – Key offerings
• Exhibit 142: Dr Reddys Laboratories Ltd. – Segment focus

• 12.10 Enorama Pharma AB 
• Exhibit 143: Enorama Pharma AB – Overview
• Exhibit 144: Enorama Pharma AB – Product / Service
• Exhibit 145: Enorama Pharma AB – Key news
• Exhibit 146: Enorama Pharma AB – Key offerings

• 12.11 Imperial Brands Plc 
• Exhibit 147: Imperial Brands Plc – Overview
• Exhibit 148: Imperial Brands Plc – Business segments
• Exhibit 149: Imperial Brands Plc – Key news
• Exhibit 150: Imperial Brands Plc – Key offerings
• Exhibit 151: Imperial Brands Plc – Segment focus

• 12.12 Japan Tobacco Inc. 
• Exhibit 152: Japan Tobacco Inc. – Overview
• Exhibit 153: Japan Tobacco Inc. – Business segments
• Exhibit 154: Japan Tobacco Inc. – Key news
• Exhibit 155: Japan Tobacco Inc. – Key offerings
• Exhibit 156: Japan Tobacco Inc. – Segment focus

• 12.13 Johnson and Johnson 
• Exhibit 157: Johnson and Johnson – Overview
• Exhibit 158: Johnson and Johnson – Business segments
• Exhibit 159: Johnson and Johnson – Key news
• Exhibit 160: Johnson and Johnson – Key offerings
• Exhibit 161: Johnson and Johnson – Segment focus

• 12.14 Perrigo Co. Plc 
• Exhibit 162: Perrigo Co. Plc – Overview
• Exhibit 163: Perrigo Co. Plc – Business segments
• Exhibit 164: Perrigo Co. Plc – Key news
• Exhibit 165: Perrigo Co. Plc – Key offerings
• Exhibit 166: Perrigo Co. Plc – Segment focus

• 12.15 Pfizer Inc. 
• Exhibit 167: Pfizer Inc. – Overview
• Exhibit 168: Pfizer Inc. – Product / Service
• Exhibit 169: Pfizer Inc. – Key news
• Exhibit 170: Pfizer Inc. – Key offerings

• 12.16 Philip Morris International 
• Exhibit 171: Philip Morris International – Overview
• Exhibit 172: Philip Morris International – Business segments
• Exhibit 173: Philip Morris International – Key offerings
• Exhibit 174: Philip Morris International – Segment focus

• 12.17 Tvape 
• Exhibit 175: Tvape – Overview
• Exhibit 176: Tvape – Product / Service
• Exhibit 177: Tvape – Key offerings

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 178: Inclusions checklist
• Exhibit 179: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 180: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 181: Research methodology
• Exhibit 182: Validation techniques employed for market sizing
• Exhibit 183: Information sources

• 13.5 List of abbreviations 
• Exhibit 184: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio